Serge Saxonov - 14 Sep 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Issuer symbol
TXG
Transactions as of
14 Sep 2022
Net transactions value
$0
Form type
4
Filing time
16 Sep 2022, 17:34:47 UTC
Previous filing
14 Sep 2022
Next filing
23 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Award $0 +142,075 $0.000000 142,075 14 Sep 2022 Class A Common Stock 142,075 $33.67 Direct F1
transaction TXG Performance-based Restricted Stock Units Award $0 +213,112 $0.000000 213,112 14 Sep 2022 Class A Common Stock 213,112 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3rd of the shares subject to the option vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date.
F2 Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date.